Model for Prognosis of Elderly Gastric Cancer Patients
Development and Validation of a Machine Learning Model for Predicting the Prognosis of Elderly Gastric Cancer Patients: A Multi-Center Study in China
1 other identifier
observational
1,202
1 country
1
Brief Summary
This study aims to develop and validate a Random Survival Forest (RSF) model for predicting long-term survival in elderly patients following curative resection for gastric cancer. The study is a retrospective multi-center analysis involving patients aged 75 and above who underwent gastric resection from January 2009 to December 2018 at nine top-tier hospitals in China. An online prognostic tool is introduced to assist clinicians in predicting patient prognosis and customizing treatment and follow-up strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2024
CompletedFirst Submitted
Initial submission to the registry
April 26, 2024
CompletedFirst Posted
Study publicly available on registry
May 1, 2024
CompletedMay 1, 2024
April 1, 2024
3 months
April 26, 2024
April 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
5-Year Overall Survival
The proportion of patients who are alive at five years after treatment for elderly gastric cancer patients.
5 years or 60 months.
5-Year Disease-Free Survival
The proportion of patients who have survived without any signs or symptoms of gastric cancer for five years after the initial treatment.
5 years or 60 months.
Secondary Outcomes (4)
3-Year Overall Survival
3 years or 36 months.
1-Year Overall Survival
1 years or 12 months.
3-Year Disease-Free Survival
3 years or 36 months.
1-Year Disease-Free Survival
1 years or 12 months.
Eligibility Criteria
The study population comprises elderly patients, aged 75 and above, diagnosed with gastric cancer and who underwent curative gastrectomy within a ten-year period from January 2009 to December 2018. The participants were selected from nine major tertiary care centers across China, ensuring a comprehensive representation of the demographic. The selection criteria were strictly adhered to, ensuring a uniform and high-quality dataset for subsequent analysis in developing a robust prognostic model. The study's focus on the elderly demographic addresses a significant gap in prognostic tools for this age group, which often presents with distinct clinical and therapeutic challenges.
You may qualify if:
- Patients aged 75 years or older.
- Histologically confirmed diagnosis of gastric cancer.
- Patients who have undergone curative gastrectomy.
You may not qualify if:
- Patients with non-primary gastric malignancies.
- Pathological confirmation of metastatic disease (M1).
- Incomplete follow-up data or loss to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastric Surgery, Fujian Medical University Union Hospital
Fuzhou, Fujian, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chang-Ming Huang, M.D
Fujian Medical University Union Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 26, 2024
First Posted
May 1, 2024
Study Start
January 1, 2024
Primary Completion
April 1, 2024
Study Completion
April 20, 2024
Last Updated
May 1, 2024
Record last verified: 2024-04